Why the study?
Does interventional left atrial appendage closure without contrast agent maintain successful implantation and lack of procedural complications compared to routine angiography in patients undergoing LAAC?
Does interventional left atrial appendage closure without contrast agent maintain successful implantation and lack of procedural complications compared to routine angiography in patients undergoing LAAC?
Interventional LAAC with the Amulet device can be safely performed without contrast agent, potentially benefiting patients at high risk for contrast-induced nephropathy or procedural stroke.
Contrast-free LAAC maintains comparable safety; hypothesis-generating for high-risk patients, needs RCTs before practice change.
Aims: Interventional left atrial appendage closure (LAAC) is routinely performed under both echocardiographic and angiographic guiding. However, adverse outcomes, e.g., kidney injury and cerebral embolism, might be associated with injections of contrast agent into the LAA. Therefore, this prospective registry investigated the safety and feasibility of LAAC without the support of angiographic images as the default approach. Methods and results: This single-centre registry included a total of 46 non-selected, consecutive patients. In the first 25 patients (54%), LAAC with the Amulet device was performed routinely with LAA angiography prior to implantation and after release of the device. The following 21 patients (46%) were treated without the use of contrast agent. The combination of successful implantation and lack of procedural complications was regarded as the primary endpoint. Procedure time, number of recapture manoeuvres, change of device size, compression, leakage, dose area product and late thrombosis on the device were investigated as secondary endpoints. Besides the longer fluoroscopy time and duration of the procedure in the group using angiography, no significant differences could be found. Major complications occurred equally often in both cohorts. Conclusions: Interventional LAAC with the Amulet device can be performed safely without the use of contrast agent. This approach might help to enhance the use of LAAC in patients at high risk of contrast-induced nephropathy and procedural stroke.
No takes yet. Share an insight, caveat, or question.
Wißt et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: